Healthcare
Self-defence: UK company Adaptimmune is working to improve the protective ability of T-cells to recognise infected and cancerous cells, especially in people with HIV.
Photographer: Image by Adaptimmune UK
World's First Study Of "Bionic Assassins" To Kill HIV
16 February 2010
A GREAT step forward has been taken to treat the HIV pandemic. Now, a company that can engineer immune cells to act as “bionic assassins” is to trial it with HIV patients.
read more




















